Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by QUINN, F. R.
Right arrow Articles by MILNE, G. W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by QUINN, F. R.
Right arrow Articles by MILNE, G. W. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 Oxford University Press

research-article

Toxicities Derived from Anti-tumor Screening Data

FRANK R. QUINN and GEORGE W. A. MILNE

Information Technology Branch, Developmental Therapeutics Program, Division of Cancer Treatment National Cancer Institute Bethesda, Maryland 20892

Toxicities Derived from Anti-tumor Screening Data. QUINN, F. R., AND MILNE, G. W. A. (1986). Fundam. Appl. Toxicol. 6, 270–277. A recent study published by the National Academy of Sciences emphasized an acute shortage of data on the toxic effects of chemicals in man and animals. This shortage makes risk assessment difficult and impacts seriously on the development of a sound environmental policy. The National Cancer Institute, in its search for effective anticancer agents, has determined quantitative as well as qualitative toxicities for a large number of chemicals. Probit analysis was used to derive lethalities (LD50s) from data obtained in the process of testing anti-cancer agents in mice. These data were compared with those derived from testing those same agents in normal mice and it was found that a correlation exists between the two toxicities. Toxicities derived from NCI testing in normal animals were compared with published values and a similar correlation was found. LD50s were derived for all compounds tested in normal mice as well as those tested in mice bearing L12l0 and P388 lymphocytic leukemias. Over 32,000 LD50s were derived for 22,597 unique compounds.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.